In: Molecular oncology, 2015, vol. 9, no. 6, p. 1194-1206
STAT3 is a key element in many oncogenic pathways and, like other transcription factors, is an attractive target for development of novel anticancer drugs. However, interfering with STAT3 functions has been a difficult task and very few small molecule inhibitors have made their way to the clinic. OPB‐31121, an anticancer compound currently in clinical trials, has been reported to affect...
|
In: Proceedings of the national academy of sciences of the United States of America, 2017, vol. 114, no. 25, p. E4924-E4933
In addition to its canonical role in nuclear transcription, signal transducer and activator of transcription 3 (STAT3) is emerging as an important regulator of mitochondrial function. Here, we demonstrate that a novel inhibitor that binds with high affinity to the STAT3 SH2 domain triggers a complex cascade of events initiated by interference with mitochondrial STAT3 (mSTAT3). The...
|
Thèse de doctorat : Université de Fribourg, 2000 ; nr. 1321.
Apoptosis is a key event occurring in living organisms. In order to maintain tissue homeostasis, a comparable number of cells have to die to compensate for the cells produced by mitosis. However in many diseases this mechanism is altered. Once a malignancy is established, the conventional approach is to treat cells with drugs able to induce apoptosis. Although the execution of apoptosis is a...
|
